Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience
Launched by STANFORD UNIVERSITY · Nov 22, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how digital programs can help newly diagnosed cancer patients improve their health and wellbeing. Participants will be randomly assigned to one of two online programs, both designed by experts at Stanford University. Throughout the study, participants will fill out questionnaires to share their experiences, complete digital courses, and collect blood samples at home to help researchers see how their bodies are responding to treatment over time.
To be eligible for this study, participants must have a recent diagnosis of certain types of cancer (stages I-III) and be starting or currently receiving treatment, like chemotherapy or immunotherapy. They should be at least 18 years old, fluent in English, and living in the United States with access to a computer or smartphone. The trial is open to all genders. It’s important to note that individuals currently being treated for severe mental health issues, such as depression or anxiety, cannot participate. This study aims to provide valuable insights into how mindset and resilience can affect the cancer experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Initial (non-recurrent) diagnosis of non-metastatic (stage I-III) or hematological malignancy.
- • Diagnosis in the past 150 days.
- • Currently receiving active systemic treatment or with a planned systemic treatment (including chemotherapy, immunotherapy or other targeted therapies).
- • Eighteen years of age or older.
- • Fluent in English.
- • Currently reside in the United States.
- • Access to a computer, tablet, or smartphone (a mobile phone that performs many of the functions of a computer, typically including a touchscreen interface, internet access, and an operating system capable of running downloaded applications, or tablet that runs iOS or Android software, with cellular data service or wifi access).
- Exclusion Criteria:
- • Failure to meet inclusion criteria.
- • Currently receiving treatment for severe depression, severe anxiety, bipolar disorder, post-traumatic stress disorder, or schizophrenia.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Alia J Crum, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported